Commitment to Action

Gene-RADAR for Ebola: Stopping the Next Outbreak

Commitment by

Nanobiosym

In 2015, Nanobiosym Diagnostics, Inc. committed to accelerate the validation, launch, and uptake of NBS’s XPrize winning Gene-RADAR technology platform to provide resource limited settings with the tools and data necessary to prevent, detect, and rapidly respond to an Ebola outbreak before it becomes a pandemic. This commitment will involve a multi-phased approach that will fully leverage the breakthrough Gene-RADAR platform (for real-time, point of care, fully automated, quantitative, presymptomatic Ebola diagnosis) to create affordable access and adoption to the countries and programs in the most urgent need. NBS will pilot this work in Liberia but eventually hopes to make this technology available to all countries interested in building the capability to rapidly respond to Ebola and/or other infectious disease outbreaks.

Get Involved
Nanobiosym is working to stop the next Ebola outbreak.

Share

Tabs

Overview
Summary

Commitment

Gene-RADAR for Ebola: Stopping the Next Outbreak

Launched

2015

Est. Duration

3 years

Estimated Total Value

$5,700,000

Region

Africa

Countries

LIBERIA

Commitment by

Nanobiosym